451 related articles for article (PubMed ID: 27430748)
1. Non-invasive metabolic imaging of brain tumours in the era of precision medicine.
Kim MM; Parolia A; Dunphy MP; Venneti S
Nat Rev Clin Oncol; 2016 Dec; 13(12):725-739. PubMed ID: 27430748
[TBL] [Abstract][Full Text] [Related]
2. Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.
Waerzeggers Y; Ullrich RT; Monfared P; Viel T; Weckesser M; Stummer W; Schober O; Winkeler A; Jacobs AH
Br J Radiol; 2011 Dec; 84 Spec No 2(Spec Iss 2):S179-95. PubMed ID: 22433828
[TBL] [Abstract][Full Text] [Related]
3. Multimodality assessment of brain tumors and tumor recurrence.
Heiss WD; Raab P; Lanfermann H
J Nucl Med; 2011 Oct; 52(10):1585-600. PubMed ID: 21840931
[TBL] [Abstract][Full Text] [Related]
4. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
5. [Use of amino acid PET in the Diagnostic and Treatment Management of cerebral gliomas].
Galldiks N; Langen KJ
Fortschr Neurol Psychiatr; 2012 Jan; 80(1):17-23. PubMed ID: 22161228
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography imaging in gliomas: applications in clinical diagnosis, for assessment of prognosis and of treatment effects, and for detection of recurrences.
Heiss WD
Eur J Neurol; 2017 Oct; 24(10):1255-e70. PubMed ID: 28799683
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance metabolic imaging of glioma.
Metellus P; Figarella-Branger D
Sci Transl Med; 2012 Jan; 4(116):116ps1. PubMed ID: 22238331
[TBL] [Abstract][Full Text] [Related]
8. Imaging biomarkers of brain tumour margin and tumour invasion.
Price SJ; Gillard JH
Br J Radiol; 2011 Dec; 84 Spec No 2(Spec Iss 2):S159-67. PubMed ID: 22433826
[TBL] [Abstract][Full Text] [Related]
9. Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients.
Hutterer M; Hattingen E; Palm C; Proescholdt MA; Hau P
Neuro Oncol; 2015 Jun; 17(6):784-800. PubMed ID: 25543124
[TBL] [Abstract][Full Text] [Related]
10. Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate.
Andronesi OC; Loebel F; Bogner W; Marjańska M; Vander Heiden MG; Iafrate AJ; Dietrich J; Batchelor TT; Gerstner ER; Kaelin WG; Chi AS; Rosen BR; Cahill DP
Clin Cancer Res; 2016 Apr; 22(7):1632-41. PubMed ID: 26534967
[TBL] [Abstract][Full Text] [Related]
11. Imaging biomarkers in primary brain tumours.
Lopci E; Franzese C; Grimaldi M; Zucali PA; Navarria P; Simonelli M; Bello L; Scorsetti M; Chiti A
Eur J Nucl Med Mol Imaging; 2015 Apr; 42(4):597-612. PubMed ID: 25520293
[TBL] [Abstract][Full Text] [Related]
12. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
[TBL] [Abstract][Full Text] [Related]
13. Progress in neuro-oncology: imaging in-phase!
Cottier JP
Diagn Interv Imaging; 2014 Oct; 95(10):905. PubMed ID: 25288181
[No Abstract] [Full Text] [Related]
14. Biomarkers usher in era of personalized care for malignant glioma patients.
Chakravarti A; Palanichamy K; Bell EH
CNS Oncol; 2012 Sep; 1(1):3-6. PubMed ID: 25054291
[No Abstract] [Full Text] [Related]
15. The development of functional imaging in the diagnosis, management and understanding of childhood brain tumours.
Peet AC; Leach MO; Pinkerton CR; Price P; Williams SR; Grundy RG
Pediatr Blood Cancer; 2005 Feb; 44(2):103-13. PubMed ID: 15495214
[TBL] [Abstract][Full Text] [Related]
16. IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma.
Kickingereder P; Sahm F; Radbruch A; Wick W; Heiland S; Deimling Av; Bendszus M; Wiestler B
Sci Rep; 2015 Nov; 5():16238. PubMed ID: 26538165
[TBL] [Abstract][Full Text] [Related]
17. From K-space to Nucleotide: Insights Into the Radiogenomics of Brain Tumors.
Elshafeey N; Hassan I; Zinn PO; Colen RR
Top Magn Reson Imaging; 2017 Feb; 26(1):33-41. PubMed ID: 28079715
[TBL] [Abstract][Full Text] [Related]
18. On the Utility of Short Echo Time (TE) Single Voxel 1H-MRS in Non-Invasive Detection of 2-Hydroxyglutarate (2HG); Challenges and Potential Improvement Illustrated with Animal Models Using MRUI and LCModel.
Heo H; Kim S; Lee HH; Cho HR; Xu WJ; Lee SH; Park CK; Park S; Choi SH; Kim H
PLoS One; 2016; 11(1):e0147794. PubMed ID: 26820720
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetics of low-grade gliomas: genomic alterations guiding diagnosis and therapeutic intervention. 11th annual Frye-Halloran Brain Tumor Symposium.
Jones PS; Dunn GP; Barker FG; Curry WT; Hochberg FH; Cahill DP
Neurosurg Focus; 2013 Feb; 34(2):E9. PubMed ID: 23373454
[TBL] [Abstract][Full Text] [Related]
20. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging.
Ozsunar Y; Mullins ME; Kwong K; Hochberg FH; Ament C; Schaefer PW; Gonzalez RG; Lev MH
Acad Radiol; 2010 Mar; 17(3):282-90. PubMed ID: 20060750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
